Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome

Fertility and Sterility

Volumn 79, Issue 6, 2003, Pages 1358-1364

  Yildirim, Basak ^a   Sabir, Nuran ^a   Kaleli, Babur ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Fat distribution; Polycystic ovary syndrome; Ultrasonography; Visceral fat

Indexed keywords

CHOLESTEROL; ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE; TRIACYLGLYCEROL;

ABDOMEN; ADULT; AREA UNDER THE CURVE; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID ANALYSIS; LIPID METABOLISM; LIPID STORAGE; METABOLIC DISORDER; METABOLISM; MULTIPLE REGRESSION; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037835471     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00265-6     Document Type: Article

References (30)

1. Solomon C.G. The epidemiology of polycystic ovary syndrome prevalence and associated disease risks . Endocrinol Metab Clin North Am. 28:1999;247-263.
2. Holte J., Bergh T., Berne C., Lithell H. Serum lipid profile in women with PCOS relation to anthropometric, endocrine and metabolic variables . Clin Endocrinol. 41:1994;463-471.
3. Ehrmann D.A., Barnes R.B., Rosenfield R.L., Cavaghan M.K., Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 22:1999;141-146.
4. Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistance states. Endocr Rev. 12:1991;3-6.
5. Chang R.J., Nakamura R.M., Judd H.L., Kaplan S.A. Insulin resistance in non-obese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 57:1983;356-359.
6. Jialal I, Naiker ), Reddi K, Moddley J, Joubert SM. Evidence for insulin resistance in non-obese patients with p olycystic ovarian disease. J Clin Endocrinol Metab1987;64:1066-72.
7. Dunaif A., Segal K., Futterweit W., Dobbrjansky A. Profound peripheral resistance independent of obesity in polycystic ovary syndrome. Diabetes. 38:1989;1165-1171.
8. ConwayGS, AgrawalR, BetteridgeDJ, JacopsHS. Risk factors for coronary artery disease in lean and obese women with PCOS. Clin Endocrinol 1992;37:109-6.
9. Fujioka S., Matsuzawa Y., Tokunaga K., Seiichiro T. Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 36:1987;54-59.
10. Matsuzawa Y., Shimomura I., Nakamura T., Keno Y., Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Ann N Y Acad Sci. 748:1995;399-406.
11. Rebuffe-Scrive M., Anderson B., Olbe L., Bjorntorp P. Metabolism of adipose tissue in severely obese men and women. Metabolism. 39:1990;1021-1025.
12. Nakamura T., Tokunaga K., Shimomura I., Nishida M., Yoshida S., Katoni K. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis. 107:1994;239-246.
13. Yamamoto M., Egusa G., Hara H., Yamakido M. Association of intraabdominal fat and carotid atherosclerosis in non-obese middle aged men with normal glucose tolerance. Int J Obesity. 21:1997;948-951.
14. Sabir N., Sermez Y., Kazil S., Zencir M. Correlation of abdominal fat accumulation and liver steatosis importance of ultrasonographic and anthropometric measurements . Eur J Ultrasound. 14:2001;121-128.
15. Armellini F., Zamboni M., Rigo L., Todesco T., Bergamo-Andreis I.A., Procacci C. The contribution of sonography of the measurements of intra-abdominal fat. J Clin Ultrasound. 18:1990;563-567.
16. Dixson A.K. Abdominal fat assessed by computed tomography. Sex difference in distribution. Clin Radiol. 34:1983;189-191.
17. Suzuki R., Watanabe S., Hirai Y., Akiyama K., Nishide T., Matsushima Y. Abdominal wall index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med. 95:1993;309-314.
18. Guagnano M.T., Ballone E., Merlitti D., Murri R., Pace-Palitti V., Pilotti R., et al. Association between anthropometric and ultrasound measurements of fatness with ambulatory blood pressure monitoring in obese women. Int J Obesity. 21:1997;632-636.
19. Kirchengast S., Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod. 16:2001;1255-1260.
20. Wajchenberg B.L., Bosco A., Marone M.M., Levin S., Rocha M., Lerario A.C., et al. Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab. 80:1995;2791-2794.
21. Gray D.S., Fujioka K., Colletti P.M., Kim H., Devine W., Cuyegkeng T., et al. Magnetic-resonance imaging used for determining fat distribution in obesity and diabetes. Am J Clin Nutr. 54:1991;623-627.
22. Staten M.A., Totty W.G., Kohrt W.M. Measurement of fat distribution by magnetic resonance imaging. Invest Radiol. 24:1989;345-349.
23. Mahabeer S., Jialal I., Norman R.J. Insulin and C-peptide secretion in non-obese patients' ovarian disease. Horm Metab Res. 21:1989;502-506.
24. Meirow D., Raz I., Yossepowitch O., Brzezinski A., Rosler A., Schenker J.G., et al. Dyslipidaemia in polycystic ovarian syndrome different groups, different aetiologies? Hum Reprod. 11:1996;1848-1853.
25. Robinson S., Henderson A.D., Gelding S.V., Kiddy D., Niththyananthan R., Bush A., et al. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf). 44:1996;277-284.
26. Norman R.J., Hague W.M., Masters S.C., Wang X.J. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod. 10:1995;2258-2261.
27. Graf MJ, Richards CJ, Brown SV, Meissner L, Dunaif A. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women. Clin Endocrinol (Oxf) 1990;33:119-113.
28. Wahrenberg H., Ek I., Reynisdottir S., Carlström K., Bergqvist A. Arner preperitoneal. Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 84:1999;2182-2187.
29. Lithell H., Boberg J. The lipoprotein-lipase activity of adipose tissue from different sites in obese women and the relationship to the cell size. Int J Obesity. 2:1978;47-52.
30. Ek I., Arner P., Ryden M., Holm C., Thorne A., Hoffstedt J., et al. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes. 51:2002;484-492.